¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"adipose tissue disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hunger disease
    ±â¾Æº´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • hydatid disease
    Æ÷Ãæº´
  • hyperbaric disease
    °í¾Ðº´
  • iatrogenic disease
    ÀÇÀκ´, ÀÇ¿øº´
  • iron-storage disease
    öÃàÀûÁúȯ
  • ischemic bowel disease
    ÇãÇ÷Àå¿°, ÇãÇ÷âÀÚ¿°
  • ischemic heart disease
    ÇãÇ÷½ÉÀ庴
  • immune deposit disease
    ¸é¿ªÄ§Âøº´
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • immunological disease
    ¸é¿ªº´, ¸é¿ªÁúȯ
  • immunoproliferative disease
    ¸é¿ª¼¼Æ÷Áõ½Äº´, ¸é¿ªÁõ½ÄÁúȯ
  • imported disease
    ¼öÀÔº´
  • inclusion disease
    Æ÷ÇÔüº´, ºÀÀÔüº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • heavy-chain disease
    Áß°í¸®º´
  • helminthic disease
    ¿¬Ã溴
  • hemisoimmune disease
    ÀûÇ÷±¸µ¿Á¾¸é¿ªº´
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemolytic disease
    ¿ëÇ÷º´, ¿ëÇ÷Áúȯ
  • hemorrhagic disease
    ÃâÇ÷º´
  • hemp disease
    ¸¶¼¶À¯º´
  • hepatolenticular disease
    °£·»ÁîÇÙº´
  • hepatolienal disease
    °£Áö¶óº´, °£ºñÀ庴
  • hereditary disease
    À¯Àüº´
  • heredoconstitutional disease
    À¯ÀüüÁúº´
  • heredodegenerative disease
    À¯Àüº¯¼ºÁõ
  • herpetic disease
    Ç츣Æä½ºº´
  • hidebound disease
    (¢¡scleroderma) ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • hip-joint disease
    ¾ûµ¢°üÀýº´, °í°üÀýº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • Pseudo Hurler disease
    °¡¼ºÇæ·¯º´
  • Raynaud s disease
    ·¹À̳뺴.
  • Refsum s disease
    ·¹ÇÁ¼ûº´.
  • Refsums disease
    ·¹ÇÁ¼û º´
  • Ritter disease
    ¸®ÅÍ º´
  • Rombergs disease = Romberg syndrome
    ·Òº£¸£Å©º´
  • Schilder s disease
    ½Ç´õº´.
  • Sheehans disease
    ½ÃÇѺ´
  • Sj?rens disease
    ¼î±×·»º´, ¼î±×·»ÁõÈıº
  • Stargardts disease=>fundus flavimaculatus
    ½ºÅ¸°¡¸£Æ®º´
  • Stills disease
    ½ºÆ¿ º´
  • Takahara disease
    ´ÙÄ«Ç϶óº´
  • Takayasu disease
    Ÿī¾ß¼öº´
  • Theilers disease
    ŸÀÏ·¯¸¶¿ì½º Ư¹ß¼º ³úô¼ö¿°
  • Thornwaldts disease
    Àεγ¶¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • submucous tissue
    Á¡¸·¹ØÁ¶Á÷
  • subserous tissue
    À帷¹ØÁ¶Á÷
  • supporting tissue
    ÁöÁöÁ¶Á÷(¡­ðÚòÄ).
  • surrounding tissue
    ÁÖÀ§Á¶Á÷(ñ²êÌðÚòÄ).
  • surrounding tissue
    ÁÖÀ§ Á¶Á÷(ñ²êÌðÚòÄ).
  • sustentacular tissue
    ÁöÁÖÁ¶Á÷(¡­ðÚòÄ).
  • target tissue
    Ç¥ÀûÁ¶Á÷(øöîÜðÚòÄ)
  • tissue
    Á¶Á÷
  • tissue
    Á¶Á÷(ðÚòÄ).
  • tissue
    Á¶Á÷(ðÚòÄ)
  • tissue analysis
    Á¶Á÷ºÐ¼®(¡­ÝÂà°)
  • tissue anoxia
    Á¶Á÷¹«»ê¼ÒÁõ(¡­Ùíß«áÈñø)
  • tissue anoxia
    Á¶Á÷¹«»ê¼ÒÁõ(¡­Ùíß«áÈñø).
  • tissue antibody
    Á¶Á÷Ç×ü
  • tissue block
    Á¶Á÷ºí·Ï(ðÚòÄ¡­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
CID cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ...
CLD chloride diarrhea; chronic liver disease; chronic lung disease; congenital limb deficiency; crystal ...
CSPINE corticosteroid use, seropositive RA, peripheral joint destruction, involvement of cervical nerves, n...
DILD diffuse infiltrative lung disease; diffuse interstitial lung disease
DPD Department of Public Dispensary; depression pure disease; desoxypyridoxine; diffuse pulmonary diseas...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
TIMP-1 Tissue inhibitor of metalloproteinase 1
TIMP-3 Tissue inhibitor of metalloproteinase-3
TIMP tissue inhibitor of MMP
TK Tissue kallikrein
TMA Tissue microarray
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • disease of the pancreas
    ÃéÀå Áúȯ
  • double vessel disease
    ÀÌÁß °ü»ó µ¿¸Æ Áúȯ
  • Ebstein anomaly disease
    ¿¦½ºÅ¸ÀÎ º´
    ¿ì½É½Ç°ú ¿ì½É¹æ »çÀÌ¿¡ ÀÖ´Â »ï÷ÆÇ
  • epizootic hemorrhagic disease
    °¡Ãà À¯Ç༺ ÃâÇ÷¼º Áúȯ
  • F1 hybrid disease
    F1 ÇÏÀ̺긮µå Áúȯ
    ÇÑÂÊ ¾î¹öÀÌÀÇ ¸é¿ª ´ã´ç ¼¼Æ÷¸¦ F
  • Fabry Anderson disease
    ÆÐºê¸® ¾Ø´õ½¼ Áúȯ
  • febrile disease
    ¿­¼º Áúȯ
  • fifth disease
    Á¦ 5º´
  • flat Bowen's disease
    ÆíÆò Bowen Áúȯ
  • focal disease
    ÃÊÁ¡¼º Áúȯ
  • following chronic infectious disease
    ¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
  • Fordyce's disease
    Æ÷¿À´ÙÀ̽º º´
  • Hailey-Hailey disease
    ÇìÀϸ® ÇìÀϸ® º´
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â. °æºÎ, ¾×¿Í, ¼­ÇýºÎ¿¡ ÀÛÀº ¼öÆ÷ ¹× Å« ¼öÆ÷°¡ ¹Ýº¹ÇÏ¿© ¹ß»ýÇÏ´Â Èñ±ÍÇÑ À¯Àü¼º Áúȯ. »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏ¸ç ºÒ¿ÏÀüÇÑ Ç¥ÇöÀ²À» °¡Áø´Ù. ¸ð³¶ °¢È­Áõ°ú À¯»çÇÏ°Ô »ý°¢ÇÏ¸ç ºÎÂø ¹Ý³» ¼¼Æ÷°£ Á¢ÃËÃþÀÇ ¼Ò½Ç ¶Ç´Â ´ç±è¼¼»çÀÇ °áÇÔÀ» µé°í ÀÖ´Ù.
  • hand and foot disease
    ¼Õ¹ß º´, ¼öÁ· º´
  • hand foot and mouth disease
    ¼öÁ·±¸ º´, ¼Õ¹ßÀÔ º´, ¼Õ¹ß ¹× ±¸°­ Áúȯ, ¼Õ-¹ß-±¸°­ Áúȯ
    1. ÄÛ»çŰ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ »ý±ä µå¹® Àå ¹ÙÀÌ·¯½º¼º °¨¿° Áúȯ. 2. °æÁõÀ̳ª ´ë´ÜÈ÷ °¨¿°·ÂÀÌ ÀÖ´Â ¼Ò¾ÆÀÇ ¹ÙÀÌ·¯½º º´À¸·Î¼­, ÀÔ, ¼öÁ·¿¡ ¼öÆ÷¼º º´º¯À» º¼ ¼ö ÀÖ´Â °ÍÀÌ ±× Ư¡ÀÌ´Ù. 3. ÄÛ»çŰ ¹ÙÀÌ·¯½º A16ÀÇ °¨¿°À¸·Î ¼Õ, ¹ß, ÇÏÁö, ÀÔ¼Ó¿¡ ÀÛÀº ¼öÆ÷°¡ »ý±â´Â Áúº´. ÁÖ·Î Á¥¸ÔÀÌ¿¡°Ô Àß ³ªÅ¸³ª´Â °¨¿°ÁõÀε¥, 6°³¿ù ¹Ì¸¸ÀÇ Á¥¸ÔÀÌ¿Í 4¼¼ ÀÌ»óÀÇ ¾î¸°ÀÌ¿¡°Ô´Â µå¹°°Ô °¨¿°µÈ´Ù. ³²ÀÚ ¾î¸°ÀÌ¿¡°Ô ¸¹°í ¼ºÀο¡°Ôµµ ³ªÅ¸³­´Ù. ¿©¸§Ã¶¿¡ ÁÖ·Î ¹ßº´Çϰí 4~6Àϰ£ÀÇ Àẹ±â¸¦ °ÅÄ£´Ù. Áõ¼¼´Â ´ëü·Î °¡º±´Ù. 1957³â ij³ª´Ù Åä·ÐÅä¿¡¼­ À¯ÇàÇßÀ» ¶§ ·Îºó½¼ µîÀÌ ÀÌ Áõ¼¼¿¡ ´ëÇØ ±â·ÏÇß°í, ´º¿åÁÖ ÄÛ»çŰ¿¡¼­ óÀ½À¸·Î ÀÌ ¹ÙÀÌ·¯½º¸¦ ºÐ¸®½ÃŲ µ¥¼­ ±× Áö¹æ¸íÀ» µû¼­ ¸í¸íÇÏ¿´´Ù. ±× ´ç½Ã º´¿øÃ¼´Â ÄÛ»çŰ A16 ¹ÙÀÌ·¯½º¿´À¸³ª, ÈÄ¿¡ ÄÛ»çŰ A5, A10°ú ¿£Å×·Î ¹ÙÀÌ·¯½º 71Çü¿¡ ÀÇÇØ¼­µµ °°Àº Áõ¼¼ÀÇ º´ÀÌ ³ªÅ¸³­´Ù´Â °ÍÀÌ ¹àÇôÁ³´Ù. ÁÖ·Î ºñ¸» °¨¿°, °æ±¸ °¨¿°À¸·Î Àü¿°µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
aortoiliac occlusive disease Obstruction of the abdominal aorta and its main branches by atherosclerosis.
(05 Mar 2000)
apical interstitial lung disease <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs.
Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection.
(25 Jun 1999)
Aran-Duchenne disease A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
asbestos lung disease <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy
(12 Dec 1998)
asherman disease <radiology> Uterine synechiae, linear, lucent defects in uterus on HSG, usually secondary to endometrial trauma (D&C, etc.)
(12 Dec 1998)
atherosclerotic vascular disease <cardiology> The progressive narrowing and hardening of the arteries over time. This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
Aujeszky's disease A highly contagious herpes virus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.
(12 Dec 1998)
Aujeszky's disease virus A herpesvirus causing pseudorabies in swine.
Synonym: Aujeszky's disease virus.
(05 Mar 2000)
Australian X disease A severe encephalitis with a high mortality rate occurring in the Murray Valley of Australia; the disease is most severe in children and is characterised by headache, fever, malaise, drowsiness or convulsions, and rigidity of the neck; extensive brain damage may result; it is caused by the Murray Valley encephalitis virus (genus Flavivirus).
Synonym: Australian X disease, Australian X encephalitis.
(05 Mar 2000)
Australian X disease virus A group B arbovirus of the genus Flavivirus that causes Murray Valley encephalitis; it is transmitted by Culex mosquitoes, and also infects birds and horses.
Synonym: Australian X disease virus, MVE virus.
(05 Mar 2000)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
aviator's disease Syndrome resembling decompression sickness occurring in occupants of airplanes that reach very high altitudes without adequate pressurization of the cabin.
See: decompression sickness.
(05 Mar 2000)
Ayerza's disease <syndrome> Sclerosis of the pulmonary arteries in chronic cor pulmonale; associated with severe cyanosis, it is a condition resembling polycythemia vera but resulting from primary pulmonary arteriosclerosis or primary pulmonary hypertension and characterised by plexiform lesions of arterioles.
Synonym: Ayerza's disease, cardiopathia nigra, plexogenic pulmonary arteriopathy.
(05 Mar 2000)
Azorean disease A rare form of hereditary ataxia, characterised by onset in early adult life of progressive, spinocerebellar and extrapyramidal disease with external ophthalmoplegia, rigidity dystonia symptoms, and, often, peripheral amyotrophy; found predominantly in people of Azorean ancestry; autosomal dominant inheritance.
Synonym: Azorean disease, Portuguese-Azorean disease.
Origin: Surnames of two families studied in major descriptions of the disease.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á